tirzepatide 3mg tablets Treatment contain semaglutide Switch to Tirzepatide in T2D

In the head-to-head SURMOUNT-5 trial, tirzepatide achieved 20.2% mean weight reduction compared to 13.7% with semaglutide at 72 weeksa difference of 6.5 percentage points

GLP-1s may offer a dual benefit for patients with chronic conditions like diabetes or obesity who are also struggling with a substance use disorder: one medication can treat both conditions at once, Al-Aly said

Lets explore some of the key concerns

If you get your medication through Noom Med, be sure to track your side effects alongside any drinking and note how it makes you feel

With tirzepatides recent approval to treat OSA in patients with obesity, sleep medicine providers must educate themselves and their patients on the risks and benefits of medications from compounding pharmacies

If mood disturbances are severe or persistent, evaluation by a mental health professional is appropriate